.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Breez is stocked at 298 licensed dispensaries across California, Illinois, and Oklahoma, 222 of them in California, with the deepest coverage in Los Angeles, San Diego, San Francisco, La Mesa, and Sacramento. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Breez is concentrated in Capsules at 87.05% share with August 2026 Capsules sales up 0.30% month over month but down 27.15% year over year, while Tincture & Sublingual holds 5.60% share with a 15.43% MoM increase against a 10.17% YoY decline. Edible sits at 6.87% share with sales down 22.69% MoM and 35.60% YoY, and Vapor Pens has fallen to 0.48% share with a 45.02% MoM drop and 90.48% YoY contraction. With brand-wide sales down 29.31% YoY and the average price up 13.31% YoY to $39.26, the mix indicates reliance on a stabilizing Capsules base and a tactical pivot toward Tincture & Sublingual momentum to counter softness in Edible and Vapor Pens.
Holding rank 2 in Capsules in California alongside an 87.05% mix weight and a slight 0.30% MoM gain suggests Breez’s positioning remains anchored to Capsules even as category-level YoY pressure persists at 27.15%. The divergent paths—Tincture & Sublingual’s 15.43% MoM rise versus Edible’s 22.69% MoM decline—imply a shift toward function-forward formats where pricing at $44.71 in Capsules and $26.67 in Tincture & Sublingual can sustain share, while retreat from Vapor Pens at 0.48% share and 45.02% MoM decline reduces exposure to a volatile, low-return lane.
Competitive Landscape
Breez is ranked #2 in California Capsules in August 2026, unchanged YoY at #2, after slipping from #1 in May–July momentum where it peaked at #1 in July 2026; meanwhile, Emerald Bay Extracts climbed from #6 to #1 with a 71.2% YoY sales increase, and ABX / AbsoluteXtracts held at #3 with a 2.7% YoY sales decline. The shift from #1 three months ago to #2 now, alongside Buddies rising from #5 to #4 with 32.9% YoY growth and Level dropping from #1 to #5 with a 59.3% YoY contraction, indicates Breez’s stable rank is being pressured by faster climbers above and below, implying that without incremental share gains the brand risks settling into a follower position behind a rapidly accelerating leader.
Notable Products
Sativa Royal Mint 20-Pack (100mg) posted the steepest decline in August 2026 at -48.36% MoM, falling to rank 8, while Hybrid Royal Mint 10-Pack (100mg) dropped -22.63% to rank 10. In contrast, Indica Extra Strength Tablet 50-Pack (1000mg) surged +156.08% MoM to rank 1, and Hybrid Extra-Strength Tablet 50-Pack (1000mg) climbed +98.51% to rank 2; together with Sativa Extra Strength Tablet 50-Pack (1000mg) at -5.39% and rank 3, four of the top ten are Capsules concentrated among Extra Strength formats. The divergence—Capsules up triple- and double-digits at the top while Edible mints lose share in the lower ranks—implies Breez is rotating demand and merchandising toward high-dose tablet formats over confection-style Edibles.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
